Diabetes Research and Clinical Practice
Volume 89, Issue 3 , Pages 239-242 , September 2010

The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT

Received 9 March 2010 ,Revised 13 April 2010 ,Accepted 19 April 2010.

References 

  1. Prospective Diabetes Study (UKPDS) Group UK. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J. 1996;352:854–865
  2. Heart Outcome Prevention Evaluation Study Investigators: effects of ramipril on cardiovascular and microvascular outcome in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet. 2000;355:253–259
  3. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415
  4. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795–796
  5. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Deuereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Arch Intern Med. 1999;131:564–572
  6. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general population (PAMELA study). Circulation. 2001;104:1385–1392
  7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh Report of the Joint National Comittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. J Am Med Assoc. 2003;289:2560–2572
  8. Leitao CB, Canani LH, Kramer CK, Boza JC, Pinnoti AF, Gross JL. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care. 2007;30:1255–1260
  9. Strachan MW, Gough K, McKnight JA, Padfield PL. Ambulatory blood pressure monitoring: is it necessary for routine assessment of hypertension in people with diabetes?. Diabet Med. 2002;19:787–789
  10. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422–1428
  11. Ben-Dov IZ, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med. 2007;167:2139–2142
  12. Sakaguchi K, Horimatsu T, Kishi M, Takeda A, Ohnishi Y, Koike T, et al. Isolated home hypertension in the morning is associated with target organ damage in patients with type 2 diabetes. J Atheroscler Thromb. 2005;12:225–231
  13. Marchesi C, Maresca AM, Solbiati F, Franzetti I, Laurita E, Nicolini E. Masked hypertension in type 2 diabetes mellitus. relationship with left-ventricular structure and function. Am J Hypertens. 2007;20:1079–1084
  14. Cuspidi C, Meani S, Fusi V, Valerio C, Catinin E, Magrini F, et al. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens. 2005;19:471–477
  15. Mazze RS, Robinson R, Simonson G, Idrogo M, Simpson B, Kendall D, et al. Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles. Blood Press. 2004;13:335–346
  16. Leitao CB, Canani LH, Kramer CK, MoehleckeM , Pinto LC, Ricardo ED, et al. Blood pressure means rather than nocturnal dipping pattern are related to complications in type 2 diabetic patients. Diabet Med. 2008;25:308–313
  17. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26:1715–1725
  18. Eguchi K, Ikshikawa J, Hoshide S, Pickering TG, Shimada K, Kario K. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertens. 2007;9:601–607
  19. Obara T, Ohkubo T, Funahashi J, Ikikuya M, Asayama K, Metoki H, et al. The J-HOME Study Group. Isolated uncontrolled hypertension ate home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens. 2005;23:1653–1660
  20. Motz W, Dörr R. ESC/EASD joint guidelines on diabetes and cardiovascular diseases. Herz. 2009;34:21–29
  21. Ormezzano O, Baguet JP, Francois P, Quesada JL, Peirre H, Mallion JM. Is there any real target organ damage associated with white-coat normotension?. Clin Auton Res. 2004;14:160–166
  22. Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K. Subclinical arterial damage in untreated masked hypertensive subjects detected by home pressure measurement. Am J Hypertens. 2007;20:385–391

PII: S0168-8227(10)00196-8

doi: 10.1016/j.diabres.2010.04.014

Diabetes Research and Clinical Practice
Volume 89, Issue 3 , Pages 239-242 , September 2010

Article Tools